Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

NCT01921387 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Recurrent B-Cell Non-Hodgkin Lymphoma
Recurrent Hodgkin Lymphoma
Recurrent Mantle Cell Lymphoma
Recurrent T-Cell Non-Hodgkin Lymphoma
Refractory B-Cell Non-Hodgkin Lymphoma
Refractory Hodgkin Lymphoma
Refractory Mantle Cell Lymphoma
Refractory T-Cell Non-Hodgkin Lymphoma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
DRUG: Carmustine
DRUG: Cytarabine
DRUG: Etoposide
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]